Etherington Robert Dee 4

What Happened
Robert Dee Etherington, President & CEO and a director of Clene Inc. (CLNN), received a grant of options covering 65,000 shares of Common Stock on June 11, 2026. The Form 4 reports the acquisition as a derivative award (value reported $0 at grant). The exercised cost to purchase all shares would be $5.53 per share (aggregate exercise cost of $359,450), if and when the options are exercised.

Key Details

• Transaction date: June 11, 2026; Form 4 filed June 15, 2026 (filed within the required 2 business days).
• Reported transaction: Grant/award of options for 65,000 shares (reported acquisition value $0).
• Exercise price: $5.53 per share (per filing footnote).
• Vesting: 25% vests on June 11, 2027, then the remaining shares vest in 36 equal monthly installments beginning July 11, 2027.
• Shares owned after transaction: not specified in the provided filing summary.
• Plan: Granted under the Clene Inc. Amended 2020 Stock Plan.

Context
This was an option grant (a compensation award), not an open-market purchase or sale. Option grants are common executive compensation and do not itself represent immediate buying or selling of stock; future purchases would require exercising options and paying the $5.53 strike price, subject to vesting. Such awards signal a potential long-term retention/compensation incentive but are not direct endorsements to trade.